DocGo Inc (NASDAQ: DCGO) stock fell -1.36% on Friday to $5.80 against a previous-day closing price of $5.88. With 0.98 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.05 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $5.95 whereas the lowest price it dropped to was $5.78. The 52-week range on DCGO shows that it touched its highest point at $10.82 and its lowest point at $4.88 during that stretch. It currently has a 1-year price target of $12.71. Beta for the stock currently stands at 0.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DCGO was up-trending over the past week, with a rise of 1.40%, but this was down by -1.36% over a month. Three-month performance dropped to -34.76% while six-month performance fell -37.30%. The stock lost -24.58% in the past year, while it has lost -17.96% so far this year. A look at the trailing 12-month EPS for DCGO yields 0.07 with Next year EPS estimates of 0.39. For the next quarter, that number is 0.11. This implies an EPS growth rate of -60.19% for this year and 191.44% for next year.
Float and Shares Shorts:
At present, 102.41 million DCGO shares are outstanding with a float of 87.46 million shares on hand for trading. On Oct 30, 2023, short shares totaled 9.9 million, which was 9.53% higher than short shares on Sep 28, 2023. In addition to Mr. Stan Vashovsky as the firm’s Co-Founder & Non-Executive Chairman, Mr. Lee Bienstock serves as its Chief Executive Officer.
Through their ownership of 51.36% of DCGO’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 30.36% of DCGO, in contrast to 22.34% held by mutual funds. Shares owned by individuals account for 14.37%. As the largest shareholder in DCGO with 6.05% of the stake, Hood River Capital Management LLC holds 6,277,004 shares worth 6,277,004. A second-largest stockholder of DCGO, BlackRock Fund Advisors, holds 5,310,398 shares, controlling over 5.12% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in DCGO, holding 4,447,584 shares or 4.29% stake. With a 2.66% stake in DCGO, the Hood River Small-Cap Growth Fund is the largest stakeholder. A total of 2,759,201 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.44% of DCGO stock, is the second-largest Mutual Fund holder. It holds 2,537,297 shares valued at 15.07 million. iShares Russell 2000 ETF holds 1.72% of the stake in DCGO, owning 1,788,971 shares worth 10.63 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DCGO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With DCGO analysts setting a high price target of $16.00 and a low target of $10.00, the average target price over the next 12 months is $12.71. Based on these targets, DCGO could surge 175.86% to reach the target high and rise by 72.41% to reach the target low. Reaching the average price target will result in a growth of 119.14% from current levels.
Summary of Insider Activity:
Insiders traded DCGO stock several times over the past three months with 3 Buys and 5 Sells. In these transactions, 30,000 shares were bought while 33,667 shares were sold. The number of buy transactions has increased to 18 while that of sell transactions has risen to 23 over the past year. The total number of shares bought during that period was 655,404 while 6,106,322 shares were sold.